News for Tanvex BioPharma, Inc. (6541.TW)

Published at

Jan 20, 2025 2:00 AM

by gurufocus.com

positive

positive

Tanvex BioPharma Completes Acquisition of Bora Biologics, Launching New Era in Biologics Development

SAN DIEGO, CA / ACCESS Newswire / January 19, 2025 / Tanvex BioPharma, Inc. ("Tanvex"), a contract development and manufacturing organization (CDMO) for biologi

6541.TW

Read more →
Published at

Jul 14, 2021 2:00 PM

by thestreet.com

positive

positive

Akero Therapeutics Appoints Judy Chou, Ph.D., To Its Board Of Directors

SOUTH SAN FRANCISCO, Calif., July 14, 2021 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing

PFED.BA PFECL.SN PFE.MX PFE.DE PFE AKRO 6541.TW

Read more →
Published at

Jun 14, 2021 6:00 PM

by thestreet.com

mixed

mixed

Worldwide Biosimilars Industry To 2025 - By Type Of Biosimilar, Therapeutic Application And Region

DUBLIN, June 14, 2021 /PRNewswire/ -- The

AMGN.MX AMGN.BA AMGN AMG.DE VTRSV VTRS.MX VTRS VIA.DE PFED.BA PFECL.SN PFE.MX PFE.DE PFE NPKYY MYL KSPHF FYB.DE CHRS 688278.SS 688177.SS 6541.TW 4552.T 4547.T 4272.T 2696.HK 0W4N.L 068270.KS

Read more →